Global clinical trial supply experts in the UK

Pharmaceutical products supplier 2024: Global clinical trial supply services tailored for you! Strategic Sourcing – ClientPharma’s ethos is to challenge the norms and adapt to your specific needs. We understand the difficulties of multi-faceted projects with time and temperature delivery requirements. Biosimilars & Reference Medicines – ClientPharma’s clinical trial Project Management team brings proficiency in management and mitigation of risks. You can say goodbye to issues and delays and hello to peace-of-mind. Find even more details on clinical research commercial drug supply.

We are dedicated to delivering on point and on time, every time, no matter how technically challenging. As one of the top global clinical trial supply companies, our worldwide reach for clinical trial supply services provides unrivalled capabilities. Our clinical supply partners are leading global innovators and manufacturers as well as specialty distributors and local in-country experts. Benefit from the expertise of our highly experienced team who will give swift and practical advice on how best to effectively supply the products you need and exactly when and where you need them!

From sample requests to global bulk supply procurement and distribution, we work as an extension of your team to guide you through the appropriate steps to mitigate risks. From start-to-finish, we utilize our extensive expertise and breadth of knowledge to navigate: Market Intelligence; Supply Chain Planning; Risk Management; Sourcing; Waste Management; Storage & Distribution; Documentation Management; Returns, Reconciliation & Destruction Services.

On May 20th, we celebrate International Clinical Trials Day 2023. It is a day to reflect on the ground-breaking work and significant contributions of clinical trials in advancing medical research, improving patient care and transforming lives worldwide. Our heartfelt gratitude goes out to the patients participating in clinical trials and we extend our appreciation to all those that make the clinical trials possible; the researchers, physicians, nurses, and healthcare professionals, with their unwavering dedication to bring new and innovative treatments to those in need. Together we can shape the future of medicine and make a lasting impact on the lives of millions. Happy International Clinical Trials Day! Read more information on clientpharma.com.

ClientPharma (CP), a global clinical trial supply company, specializing in the procurement of commercial drug for clinical research, announced today it has formed a strategic partnership with TrialCard, a full-service life sciences commercialization partner. As a result, global clinical supply and operations teams can now single source their commercial drug requirements by utilizing two best-in-class solution providers. ClientPharma (CP) is a specialist global clinical trial supply company providing expertise in the procurement of comparators, rescue medications, adjuvant therapies, standard-of-care, reference drugs, medical devices, ancillaries, and matching placebos. From provision of clinical research samples to bulk supplies for global pivotal trials, the company has built a strong worldwide network to provide strategic commercial drug supply solutions for all stages of clinical programs. Reducing complexity and maximizing value – that’s our mission. CP is headquartered in the United Kingdom with offices and warehousing in the US, Ireland, Belgium, and China.

Forecasts by their very definition involve a degree of uncertainty. When a company fails to meet demand it can have major implications on the drug and the pharmaceutical company. The company may experience loss in sales, a bad reputation for unreliability with customers and overworked employees. It has been reported that where the drug itself is concerned, if the launch of a medicine is delayed due to a failure in estimation, it costs on average $15 million per drug, per day. Further research has also shown that a blockbuster drug will lose $1 billion in revenue annually until capacity is developed to meet demand. Overestimations in demand generally happen when the market is at its most volatile, or, if the reach of a new drug has been over estimated. These inaccuracies can cost companies. If a product’s demand is overestimated, companies have to find ways to correct their misjudgement by cutting the price of medicines which reduces margins and by making employees redundant to pay for the excess of stock. In some cases companies also have to destroy stock that has not been sold.